Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
Go back to Leerink Partners Raises Price Target as Nevro's (NVRO) Guide Shows Increased Confidence
February 29, 2016 4:09 PM EST
REDWOOD CITY, Calif., Feb. 29, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the three months and full year ended December 31, 2015.
2015 Accomplishments & Highlights:
Achieved revenue of $69.6 million for the full year 2015, an increase of 114% as reported, over the prior year
U.S. revenue of $24.3 million for 2015
International revenue of $45.3 million for 2015, an increase of 62% constant currency and 39% as reported,...
More
February 29, 2016 4:09 PM EST
REDWOOD CITY, Calif., Feb. 29, 2016 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO) Board of Directors announced today that Michael DeMane, Nevro's Chief Executive Officer since March 2011, will transition to the role of Executive Chairman of the Board of Directors effective June 1, 2016. Â Also on that date, Rami Elghandour, Nevro's current President, will assume the role of President and Chief Executive Officer. Â Mr. DeMane intends to remain actively engaged in the company as Executive Chairman, where he will focus on long-term strategy and industry liaison... More
